⚡️ On Journal of Clinical Oncology - Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes

#KidneyCancer Wenxin (Vincent) Xu

ascopubs.org/doi/10.1200/JC…

Very proud of Lena presenting her work at AAI - outstanding job!!
Yale Cancer Center Yale Department of Immunobiology

Zoom job interview

.Eric Winer, MD 'If you are a 20 y/o white American woman, you have half the chance of dying from #breastcancer by age 50 compared to a black American woman... and the truth is, it's true for so many different kinds of #cancer . One of the areas that our whole cancer center and all…

Hedyeh Ebrahimi JAMA Network Open ACCC Genentech Sumanta K. Pal, MD, FASCO Zeynep Zengin Luis A. Meza Daniela V. Castro Nick Salgia Nazli Dizman Tanya Dorff Abhishek Tripathi Neal S. Chawla 🌟So proud of our star
post-doc Hedyeh Ebrahimi’s latest achievement — a thorough and insightful publication on the barriers to oncology #clinicaltrials 🤩 Her hard work is paving the way for meaningful advancements in the field. Great job! #ACORI ACCC Genentech Sumanta K. Pal, MD, FASCO

ALL OF THE EMOTIONS 🥹

#F1 #MiamiGP

Lewis Hamilton clapping for Lando Norris after the race! 🧡🧡

LANDO NORRIS WINS THE MIAMI GRAND PRIX!!!! 🧡🌴

IT'S A MAIDEN WIN FOR THE @MCLARENF1 DRIVER 🏁😱

SIMPLY STUNNING!!!!!

#F1 #MiamiGP

⭐️Congrats Hedyeh Ebrahimi and amazing team!

‼️Such an important topic to address!
Sumanta K. Pal, MD, FASCO Alex Chehrazi-Raffle, MD

12 years ago today, the legendary 'inchident' happened 😅

#F1 #MiamiGP

'Caring for patients is both humbling and rewarding. You meet patients in their most vulnerable state, and they often trust you with their most valuable assets—their body and their loved ones.' Learn about #cardiology clinical fellow Sarah Abou Alaiwi, MD, medicine.yale.edu/internal-medic…

1/ Now out at Journal of Clinical Oncology! Plasma KIM-1 (pKIM-1) helps predict benign vs malignant renal masses and is prognostic for clinical outcomes.
ascopubs.org/doi/10.1200/JC…

Congrats to our own Wenxin (Vincent) Xu from Dana-Farber Lank Center for Genitourinary Oncology on leading this multi-center elegant study focused on KIM-1 as a biomarker in kidney masses!

Journal of Clinical Oncology Journal of Clinical Oncology OncoAlert

'Antibody-drug conjugates are a novel way to improve chemotherapy delivery, but their role is still evolving.” Dana-Farber's Brad McGregor, MD, (@BradMcG04), featured in Verywell Health Health on the promise and challenges with these cancer treatments.

➡️ ms.spr.ly/6015YRRgX

🌟 Submit your abstracts for KCRS24 by May 6th! Join us at the Kidney Cancer Research Summit to present your work, connect with top experts, and advance kidney cancer research.
📅🔬 Deadline for submission: Monday, May 6th.

🔗 Submit today and be part of advancing kidney cancer…

Cover reveal for Too Young For Cancer!👇

🚨One weekend left before the deadline!

Don't forget to submit your #KidneyCancer abstracts!

Emre Yekedüz OncoAlert

When King Charles met King Charles

Charles Swanton UCLH

🥁 Annual meeting of all oncology community ASCO #ASCO24 is approaching💫🎉💫

💫 Please use social media actively to follow and share the excitement and enthusiasm 💻⌨️🖥️

Here is the right hashtags, handles, and profiles⬇️

Don't miss out the date! Can't wait for this great #kidney #cancer organisation! KidneyCAN Toni Choueiri, MD Renee Maria Saliby